February 27, 2025 How the House’s Budget Plan Sets the Stage for a Fiscal Showdown
Tesla: Capturing Opportunity in a Contrarian Market
Microsoft: Resilient Amid Sell-Off, 'Buy' Stance Reaffirmed
3M: Valuation Challenges Amidst Limited Growth Prospects
March 12, 2025 Features of exchanging USDC ERC20 to Bank Transfer
February 19, 2025 Why Stock Caps Matter When Building a Diversified Portfolio
February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024
January 21, 2025 Trading Stocks With AI: A Modern Approach
January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025
Enveric Biosciences (ENVB) stock forecast for 2026
Updated: March 2, 2025 (07:56)
Sector: HealthcareThe share price of Enveric Biosciences, Inc. (ENVB) now
50/200 Day Moving Average: $44.57 / $101.3
This figure corresponds to the Average Price over the previous 50/200 days. For Enveric Biosciences stocks, the 50-day moving average is the resistance level today.
For Enveric Biosciences stocks, the 200-day moving average is the resistance level today.
Are you interested in Enveric Biosciences, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Enveric Biosciences stock price in 2026. How much will one Enveric Biosciences share be worth in 2026? Is it worth taking profit / loss on ENVB stock now or waiting? What are analysts' forecasts for Enveric Biosciences stock?
We forecast Enveric Biosciences stock performance using neural networks based on historical data on ENVB stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.
Enveric Biosciences, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.
The minimum target price for Enveric Biosciences analysts is $8.32. Today 200 Day Moving Average is the resistance level (101.3 $). 50 Day Moving Average is the resistance level (44.57 $).
Historical and forecast chart of Enveric Biosciences, Inc. stock
The chart below shows the historical price of Enveric Biosciences stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ENVB stock price can be found in the table below.
Enveric Biosciences, Inc. develops cannabinoid medicines and combination therapies. It is a patient-centric biotechnology company endeavouring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments. The firm is testing natural compounds, starting with cannabinoids to provide patients and clinicians with novel prescription medicines to serve these unmet medical needs. The company is headquartered in Naples, FL.
Enveric Biosciences (ENVB) Forecast for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 2.82 | 2.52 | 3.41 | 26.10 % |
| Feb | 2.21 | 1.69 | 2.54 | 33.56 % |
| Mar | 2.50 | 2.04 | 3.04 | 33.06 % |
| Apr | 2.89 | 2.38 | 3.27 | 27.10 % |
| May | 2.80 | 2.43 | 3.12 | 22.08 % |
| Jun | 2.61 | 2.25 | 3.02 | 25.43 % |
| Jul | 3.02 | 2.31 | 3.51 | 34.08 % |
| Aug | 3.83 | 3.46 | 4.61 | 24.92 % |
| Sep | 3.93 | 3.19 | 4.79 | 33.47 % |
| Oct | 3.87 | 3.47 | 4.72 | 26.58 % |
| Nov | 3.58 | 2.85 | 4.15 | 31.32 % |
| Dec | 2.65 | 2.06 | 3.18 | 35.22 % |
Enveric Biosciences information and performance
2025 GATEWAY PLACE, SUITE 365, SAN JOSE, CA, US
Market capitalization of the Enveric Biosciences, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ENVB shares in the company outstanding by the market price of one share.
EBITDA of Enveric Biosciences is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
Enveric Biosciences price target for 2026 by month
Target values for the price of one Enveric Biosciences share for Jan 2026.
In Jan, the Positive dynamics for Enveric Biosciences, Inc. shares will prevail with possible monthly volatility of 26.098% volatility is expected.
Pessimistic target level: 2.52
Optimistic target level: 3.41
Target values for the price of one Enveric Biosciences share for Feb 2026.
In Feb, the Negative dynamics for Enveric Biosciences, Inc. shares will prevail with possible monthly volatility of 33.565% volatility is expected.
Pessimistic target level: 1.69
Optimistic target level: 2.54
Target values for the price of one Enveric Biosciences share for Mar 2026.
In Mar, the Positive dynamics for Enveric Biosciences, Inc. shares will prevail with possible monthly volatility of 33.059% volatility is expected.
Pessimistic target level: 2.04
Optimistic target level: 3.04
Target values for the price of one Enveric Biosciences share for Apr 2026.
In Apr, the Positive dynamics for Enveric Biosciences, Inc. shares will prevail with possible monthly volatility of 27.104% volatility is expected.
Pessimistic target level: 2.38
Optimistic target level: 3.27
Target values for the price of one Enveric Biosciences share for May 2026.
In May, the Negative dynamics for Enveric Biosciences, Inc. shares will prevail with possible monthly volatility of 22.083% volatility is expected.
Pessimistic target level: 2.43
Optimistic target level: 3.12
Target values for the price of one Enveric Biosciences share for Jun 2026.
In Jun, the Negative dynamics for Enveric Biosciences, Inc. shares will prevail with possible monthly volatility of 25.433% volatility is expected.
Pessimistic target level: 2.25
Optimistic target level: 3.02
Target values for the price of one Enveric Biosciences share for Jul 2026.
In Jul, the Positive dynamics for Enveric Biosciences, Inc. shares will prevail with possible monthly volatility of 34.079% volatility is expected.
Pessimistic target level: 2.31
Optimistic target level: 3.51
Target values for the price of one Enveric Biosciences share for Aug 2026.
In Aug, the Positive dynamics for Enveric Biosciences, Inc. shares will prevail with possible monthly volatility of 24.917% volatility is expected.
Pessimistic target level: 3.46
Optimistic target level: 4.61
Target values for the price of one Enveric Biosciences share for Sep 2026.
In Sep, the Positive dynamics for Enveric Biosciences, Inc. shares will prevail with possible monthly volatility of 33.470% volatility is expected.
Pessimistic target level: 3.19
Optimistic target level: 4.79
Target values for the price of one Enveric Biosciences share for Oct 2026.
In Oct, the Negative dynamics for Enveric Biosciences, Inc. shares will prevail with possible monthly volatility of 26.579% volatility is expected.
Pessimistic target level: 3.47
Optimistic target level: 4.72
Target values for the price of one Enveric Biosciences share for Nov 2026.
In Nov, the Negative dynamics for Enveric Biosciences, Inc. shares will prevail with possible monthly volatility of 31.320% volatility is expected.
Pessimistic target level: 2.85
Optimistic target level: 4.15
Target values for the price of one Enveric Biosciences share for Dec 2026.
In Dec, the Negative dynamics for Enveric Biosciences, Inc. shares will prevail with possible monthly volatility of 35.221% volatility is expected.
Pessimistic target level: 2.06
Optimistic target level: 3.18
Enveric Biosciences (ENVB) stock dividend
Enveric Biosciences last paid dividends on 04/23/2008. The next scheduled payment will be on 11/25/2019. The amount of dividends is $None per share. If the date of the next dividend payment has not been updated, it means that the issuer has not yet announced the exact payment. As soon as information becomes available, we will immediately update the data. Bookmark our portal to stay updated.
Last Split Date: 01/01/1970
Splitting of shares is an increase in the number of securities of the issuing company circulating on the market due to a decrease in their value at constant capitalization.
For example, a 5: 1 ratio means that the value of one share will decrease 5 times, the total amount will increase 5 times. It is important to understand that this procedure does not change the capitalization of the company, as well as the total value of assets held in private hands.
Related stocks from Healthcare sector
